These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22776510)
1. Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease. Bozdag-Turan I; Turan RG; Paranskaya L; Arsoy NS; Turan CH; Akin I; Kische S; Ortak J; Schneider H; Ludovicy S; Hermann T; D'Ancona G; Durdu S; Akar AR; Ince H; Nienaber CA J Transl Med; 2012 Jul; 10():143. PubMed ID: 22776510 [TBL] [Abstract][Full Text] [Related]
2. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372 [TBL] [Abstract][Full Text] [Related]
3. Impaired mobilization of CD133(+) bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes. Turan RG; Turan CH; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Kleinfeldt T; Rehders TC; Rauchhaus M; Adolph E; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Sahin K; Nienaber CA; Ince H Circ J; 2011; 75(11):2635-41. PubMed ID: 21828932 [TBL] [Abstract][Full Text] [Related]
4. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654 [TBL] [Abstract][Full Text] [Related]
5. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527 [TBL] [Abstract][Full Text] [Related]
6. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease. Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450 [TBL] [Abstract][Full Text] [Related]
7. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780 [TBL] [Abstract][Full Text] [Related]
8. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Barthelmes D; Irhimeh MR; Gillies MC; Karimipour M; Zhou M; Zhu L; Shen WY Blood Cells Mol Dis; 2013 Oct; 51(3):163-73. PubMed ID: 23714230 [TBL] [Abstract][Full Text] [Related]
9. Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. De Falco E; Avitabile D; Totta P; Straino S; Spallotta F; Cencioni C; Torella AR; Rizzi R; Porcelli D; Zacheo A; Di Vito L; Pompilio G; Napolitano M; Melillo G; Capogrossi MC; Pesce M J Cell Mol Med; 2009 Sep; 13(9B):3405-14. PubMed ID: 20196780 [TBL] [Abstract][Full Text] [Related]
10. Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease. Nollet E; Hoymans VY; Rodrigus IR; De Bock D; Dom M; Van Hoof VOM; Vrints CJ; Van Craenenbroeck EM Atherosclerosis; 2017 May; 260():138-146. PubMed ID: 28434530 [TBL] [Abstract][Full Text] [Related]
11. [Effects of exercise training on mobilization of BM-CPCs and migratory capacity as well as LVEF after AMI]. Turan RG; Brehm M; Köstering M; Bartsch T; Zeus T; Picard F; Steiner S; Fleissner T; Ilousis D; Augusta K; Kister M; Rüttger C; Schannwell CM; Strauer BE Med Klin (Munich); 2006 Mar; 101 Suppl 1():198-201. PubMed ID: 16802555 [TBL] [Abstract][Full Text] [Related]
12. Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease. Nollet E; Hoymans VY; Rodrigus IR; De Bock D; Dom M; Vanassche B; Van Hoof VO; Cools N; Van Ackeren K; Wouters K; Vermeulen K; Vrints CJ; Van Craenenbroeck EM J Cardiovasc Transl Res; 2016 Aug; 9(4):266-78. PubMed ID: 27456951 [TBL] [Abstract][Full Text] [Related]
13. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia. Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936 [TBL] [Abstract][Full Text] [Related]
14. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant. Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069 [TBL] [Abstract][Full Text] [Related]
15. Chondrogenic progenitor cells promote vascular endothelial growth factor expression through stromal-derived factor-1. Wang S; Zhou C; Zheng H; Zhang Z; Mei Y; Martin JA Osteoarthritis Cartilage; 2017 May; 25(5):742-749. PubMed ID: 27989872 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived progenitor cells in the early phase of ischemic stroke: relation with stroke severity and discharge outcome. Cesari F; Nencini P; Nesi M; Caporale R; Giusti B; Abbate R; Gori AM; Inzitari D J Cereb Blood Flow Metab; 2009 Dec; 29(12):1983-90. PubMed ID: 19724287 [TBL] [Abstract][Full Text] [Related]
17. Modified in vitro conditions for cord blood-derived long-term culture-initiating cells. Podestà M; Piaggio G; Pitto A; Zocchi E; Soracco M; Frassoni F; Luchetti S; Painelli E; Bacigalupo A Exp Hematol; 2001 Mar; 29(3):309-14. PubMed ID: 11274758 [TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
19. Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Turan RG; Bozdag-T I; Turan CH; Ortak J; Akin I; Kische S; Schneider H; Rauchhaus M; Rehders TC; Kleinfeldt T; Belu C; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Chatterjee T; Sahin K; Nienaber CA; Ince H J Cell Mol Med; 2012 Apr; 16(4):852-64. PubMed ID: 21707914 [TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]